CERo Therapeutics Inc.

NASDAQ: CERO · Real-Time Price · USD
7.97
-0.14 (-1.73%)
At close: Aug 15, 2025, 3:59 PM
7.89
-1.07%
After-hours: Aug 15, 2025, 07:49 PM EDT

CERo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-18.75 -25.32K -1.04K -7.22K
PEG Ratio
0.19 -2.02 -1.68 n/a
PS Ratio
n/a n/a n/a n/a
PB Ratio
-76.51 -4.52 281.56 13.33
P/FCF Ratio
-25.04 -11.09 -389.07 -1.74K
P/OCF Ratio
-25.04 -11.09 -636.37 -3.27K
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
-0.83 -0.11 0.26 0.02
Quick Ratio
0.50 0.38 1.38 13.88
Current Ratio
0.50 0.38 1.38 13.88
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
4.08 n/a -0.27 n/a
Return on Assets
-1.25 n/a -0.02 n/a
Return on Invested Capital
47.96 -2.02 -1.71 n/a
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a